Lung Cancer Clinical Trials in Louisiana

26 recruiting studies across 1 city

Browse by City

All Trials in Louisiana

Phase

Trial	Phase	Sponsor	Dist.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer	Phase 2/3	SWOG Cancer Research Network	<1 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])	Phase 3	National Cancer Institute (NCI)	<1 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	—	Alliance for Clinical Trials in Oncology	<1 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer	Phase 3	NRG Oncology	<1 mi
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients	—	Persephone Biosciences	<1 mi
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer	Phase 3	University of Texas Southwestern Medical Center	<1 mi
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors	Phase 1	Olema Pharmaceuticals, Inc.	<1 mi
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change	Phase 2	National Cancer Institute (NCI)	<1 mi
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia	—	University of Rochester	<1 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer	Phase 3	Eli Lilly and Company	<1 mi
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer	Phase 3	SWOG Cancer Research Network	<1 mi
Study of DF1001 in Patients with Advanced Solid Tumors	Phase 1/2	Dragonfly Therapeutics	<1 mi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements	Phase 1/2	Turning Point Therapeutics, Inc.	<1 mi
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation	—	Guardant Health, Inc.	<1 mi
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer	Phase 3	Alliance for Clinical Trials in Oncology	<1 mi
National Cancer Institute "Cancer Moonshot Biobank"	—	National Cancer Institute (NCI)	<1 mi
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma	Phase 3	Children's Oncology Group	<1 mi
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs	Phase 1/2	Krystal Biotech, Inc.	<1 mi
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier	—	Veracyte, Inc.	<1 mi
Real World Registry for Use of the Ion Endoluminal System	—	Intuitive Surgical	<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	<1 mi
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor	Phase 3	OSE Immunotherapeutics	36 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)	Phase 3	AstraZeneca	36 mi
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7	Phase 2/3	Mirati Therapeutics Inc.	36 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1	Phase 3	Summit Therapeutics	36 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.